We are live on ! Find out more
TCM

Tao Capital Management Portfolio holdings

AUM $119M
1-Year Est. Return 87.46%
This Fund
S&P 500
This Quarter Est. Return
+19.21%
1 Year Est. Return
+87.46%
3 Year Est. Return
+356.21%
5 Year Est. Return
+280.73%
10 Year Est. Return
AUM
$122M
AUM Growth
+$16.4M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
10
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 67.7%
2 Consumer Discretionary 23.01%
3 Technology 9.07%
4 Consumer Staples 0.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TWST icon
1
Twist Bioscience
TWST
$5.63B
$40.8M 33.48%
828,815
MDGL icon
2
Madrigal Pharmaceuticals
MDGL
$13B
$36.6M 29.98%
130,529
TSLA icon
3
Tesla
TSLA
$1.22T
$17.1M 13.99%
86,250
OUST icon
4
Ouster
OUST
$2.29B
$11.1M 9.07%
1,125,316
H icon
5
Hyatt Hotels
H
$18B
$10.6M 8.72%
70,000
MASS icon
6
908 Devices
MASS
$294M
$2.93M 2.4%
568,981
WRBY icon
7
Warby Parker
WRBY
$3.1B
$2.16M 1.77%
134,473
SOND
8
DELISTED
Sonder
SOND
$371K 0.3%
80,188
BHIL
9
DELISTED
Benson Hill, Inc.
BHIL
$270K 0.22%
50,705
DNA icon
10
Ginkgo Bioworks
DNA
$493M
$76K 0.06%
5,684

Similar funds

Tao Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Tao Capital Management held 10 positions worth $122M, up 16% from $106M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2024: portfolio turnover was 0%. Tao Capital Management opened no new positions and made no exits, leaving the 10-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 68% of assets, up from 66% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Tao Capital Management's ten largest holdings make up 100% of its $122M portfolio in Q2 2024.
  • Tao Capital Management opened 0 new positions and closed 0 in Q2 2024.
  • Tao Capital Management's portfolio value rose 16% quarter-over-quarter to $122M.

Based on Tao Capital Management's 13F filing for Q2 2024, filed 7 Aug 2024.